Margareta Elisabeth Björk
Directeur/Membre du Conseil chez PHARVARIS N.V.
Fortune : 503 080 $ au 30/04/2024
Profil
Dr. Margareta Elisabeth Björk is an Independent Non-Executive Director at Calliditas Therapeutics AB, an Independent Non-Executive Director at Pharvaris NV, an Independent Director at Rocket Pharmaceuticals, Inc., a Senior VP & Head-Late-stage Development at AstraZeneca PLC and an Associate Professor at University of Uppsala.
She is on the Board of Directors at Vicore Pharma Holding AB, Calliditas Therapeutics AB, Pharvaris NV, Rocket Pharmaceuticals, Inc., Björks Matematik o Mera AB, Chalmers University of Technology and Rfidcompare Europe AB.
Dr. Björk was previously employed as a Head-Diabetes & Endocrinology Unit by Uppsala University Hospital.
She also served on the board at Albireo Ltd.
She received her doctorate degree from Karolinska Institutet and a doctorate degree from the University of Uppsala.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARVARIS N.V.
0,04% | 01/04/2024 | 22 094 ( 0,04% ) | 503 080 $ | 30/04/2024 |
| 16/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Margareta Elisabeth Björk
| Sociétés | Poste | Début |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2012 |
| ROCKET PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 20/04/2020 |
| PHARVARIS N.V. | Directeur/Membre du Conseil | 01/12/2021 |
| CALLIDITAS THERAPEUTICS AB | Directeur/Membre du Conseil | 01/01/2022 |
| VICORE PHARMA HOLDING AB | Directeur/Membre du Conseil | 01/01/2023 |
| University of Uppsala | Corporate Officer/Principal | - |
| Chalmers University of Technology | Directeur/Membre du Conseil | - |
| Björks Matematik o Mera AB | Directeur/Membre du Conseil | - |
| Rfidcompare Europe AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Margareta Elisabeth Björk
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Margareta Elisabeth Björk
| Karolinska Institutet | Doctorate Degree |
| University of Uppsala | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| PHARVARIS N.V. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Health Services |
| Björks Matematik o Mera AB | |
| Rfidcompare Europe AB |
